The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Latysheva N.V.

Platonova A.S.

«Familiar Doctor» Medical Center, Moscow, Russia

Filatova E.G.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Temporomandibular disorder and cervicalgia: pathophysiology underlying the comorbidity with chronic migraine

Authors:

Latysheva N.V., Platonova A.S., Filatova E.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(1): 17‑22

DOI: 10.17116/jnevro201911901117

Read: 3260 times

Contact the author
Table of contents

TEMPOROMANDIBULAR DISORDER AND CERVICALGIA: PATHOPHYSIOLOGY UNDERLYING THE COMORBIDITY WITH CHRONIC MIGRAINE
TEMPOROMANDIBULAR DISORDER AND CERVICALGIA: PATHOPHYSIOLOGY UNDERLYING THE COMORBIDITY WITH CHRONIC MIGRAINE

To cite this article:

Latysheva NV, Platonova AS, Filatova EG. Temporomandibular disorder and cervicalgia: pathophysiology underlying the comorbidity with chronic migraine. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(1):17‑22. (In Russ.)
https://doi.org/10.17116/jnevro201911901117

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Expe­rience of Rela­tox (botulinum toxin type A) using for chro­nic migraine treatment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):134-140
Prophylactic treatment of migraine in real clinical practice. Russian Journal of Pain. 2025;(2):63-69
Vascular endo­thelial growth factor in episodic and chro­nic migraine: new approaches to unde­rstanding pathogenesis. Russian Journal of Pain. 2025;(3):17-21
Abstract:

Objective. To analyze the prevalence of various clinical forms of temporomandibular disorder (TMD) and cervicalgia in episodic (EM) and chronic migraine (CM). Material and methods. Ninety patients with CM and 42 patients with EM as defined by the International Classification of Headache Disorders (ICHD)-3 beta were recruited. TMD and sleep bruxism were diagnosed according to the DC/TMD criteria and the International Classification of Sleep Disorders (ICSD-R), respectively. Results. Myofascial pain was the most prevalent form of TMD in both EM and CM. The prevalence of TMD was higher in CM as compared to EM (60% vs. 21.4%, respectively, p=0.0001). The prevalence of bruxism was comparable across EM and CM (14.3% vs. 28.8%, respectively, p=0.08) and significantly lower than that of TMD in the CM population (28.8% vs. 60%, respectively, p=0.0001). Frequent cervicalgia (≥15 days per month) was reported by 65.5% and 21.4% of CM and EM patients, respectively (p=0.0001); 44.4% of CM patients reported neck pain immediately before or during migraine attacks only, 14.4% during the headache and interictal phases. Conclusion. The higher prevalence of pain-related TMD and cervicalgia in CM population compared to EM and the general population was shown. In CM, myofascial pain and tenderness in the masticatory and neck muscles may be caused by central sensitization (CS) with no link to temporomandibular joint or spinal pathology. Myofascial TMD and neck muscle dysfunction are an integral part of CM pathophysiology underlying headache chronification.

Keywords:

temporomandibular disorder
myofascial pain syndrome
cervicalgia
chronic migraine

Authors:

Latysheva N.V.

Platonova A.S.

«Familiar Doctor» Medical Center, Moscow, Russia

Filatova E.G.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Close metadata

References:

  1. Slade GD, Ohrbach R, Greenspan JD, Fillingim RB, Bair E, Sanders AE, Dubner R, Diatchenko L, Meloto CB, Smith S, Maixner W. Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies. J Dent Res. 2016;95(10):1084-1092. https://doi.org/10.1177/0022034516653743
  2. Macfarlane TV, Blinkhorn AS, Davies RM, Kincey J, Worthington HV. Oro-facial pain in the community: prevalence and associated impact. Community Dent Oral Epidemiol. 2002;30(1):52-60. https://doi.org/10.1034/j.1600-0528.2002.300108.x
  3. Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research.; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(1):6-27. https://doi.org/10.11607/jop.1151
  4. Hoy DG, Protani M, De R, Buchbinder R. The epidemiology of neck pain. Best Pract Res Clin Rheumatol. 2010;24(6):783-792. https://doi.org/10.1016/j.berh.2011.01.019
  5. Franco AL, Gonçalves DA, Castanharo SM, Speciali JG, Bigal ME, Camparis CM. Migraine is the most prevalent primary headache in individuals with temporomandibular disorders. J Orofac Pain. 2010;24(3):287-292.
  6. da Silva A Jr, Costa EC, Gomes JB, Leite FM, Gomez RS, Vasconcelos LP, Krymchantowski A, Moreira P, Teixeira AL. Chronic headache and comorbidities: a two-phase, population-based, cross-sectional study. Headache. 2010;50(8):1306-1312. https://doi.org/10.1111/j.1526-4610.2010.01620.x
  7. Calhoun AH, Ford S, Millen C, Finkel AG, Truong Y, Nie Y. Prevalence of neck pain in migraine. Headache. 2010;50(8):1273-1277. https://doi.org/10.1111/j.1526-4610.2009.01608.x
  8. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629-808. https://doi.org/10.1177/0333102413485658
  9. American Academy of Sleep Medicine. International classification of sleep disorders, revised: Diagnostic and coding manual. American Academy of Sleep Medicine, Chicago, 2001.
  10. Da Silva AA Jr., Brandão KV, Faleiros BE, Tavares RM, Lara RP, Januzzi E, Carvalho AB, Carvalho EM, Gomes JB, Leite FM, Alves BM, Gómez RS, Teixeira AL. Temporo-mandibular disorders are an important comorbidity of migraine and may be clinically difficult to distinguish them from tension-type headache. Arq Neuropsiquiatr. 2014;72(2):99-103. https://doi.org/10.1590/0004-282X20130221
  11. Florencio LL, de Oliveira AS, Carvalho GF, Dach F, Bigal ME, Fernández-de-Las-Peñas C, Bevilaqua-Grossi D. Association between severity of temporomandibular disorders and the frequency of headache attacks in women with migraine: a cross-sectional study. J Manipulative Physiol Ther. 2017;40(4):250-254. https://doi.org/10.1016/j.jmpt.2017.02.006
  12. Zenkevich AS, Filatova EG, Latysheva NV. Migraine and temporomandibular joint dysfunction: mechanisms of comorbidity. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(10):33-38. (In Russ.) https://doi.org/10.17116/jnevro201511510133-38
  13. Pradhan S, Choudhury SS. Clinical characterization of neck pain in migraine. Neurol India. 2018;66(2):377-384. https://doi.org/10.4103/0028-3886.227302
  14. Carvalho GF, Chaves TC, Gonçalves MC, Florencio LL, Braz CA, Dach F, Fernández de Las Peñas C, Bevilaqua-Grossi D. Comparison between neck pain disability and cervical range of motion in patients with episodic and chronic migraine: a cross-sectional study. J Manipulative Physiol Ther. 2014;37(9):641-646. https://doi.org/10.1016/j.jmpt.2014.09.002
  15. Zenkevich AS, Filatova EG, Latysheva NV. Migraine and neck pain: Mechanisms of comorbidity. Neurology, Neuropsychiatry, Psychosomatics. 2016;8(1):29-34. (In Russ.) https://doi.org/10.14412/2074-2711-2016-1-29-34
  16. Shah JP, Danoff JV, Desai MJ, Parikh S, Nakamura LY, Phillips TM, Gerber LH. Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil. 2008;89(1):16-23. https://doi.org/10.1016/j.apmr.2007.10.018
  17. Chechet EA, Tabeeva GR. Neck pain in different cephalalgias. Neurology, Neuropsychiatry, Psychosomatics. 2014;6(4):87-93. (In Russ.) https://doi.org/10.14412/2074-2711-2014-4-87-93
  18. Wober C, Brannath W, Schmidt K, Kapitan M, Rudel E, Wessely P, Wöber-Bingöl C. PAMINA Study Group. Prospective analysis of factors related to migraine attacks: The PAMINA study. Cephalalgia. 2007;27:304-314. https://doi.org/10.1111/j.1468-2982.2007.01279.x
  19. Gonçalves DA, Camparis CM, Speciali JG, Franco AL, Castanharo SM, Bigal ME. Temporomandibular disorders are differentially associated with headache diagnoses: a controlled study. Clin J Pain. 2011;27(7):611-615. https://doi.org/10.1097/AJP.0b013e31820e12f5
  20. Filatova E, Latysheva N, Kurenkov A. Evidence of persistent central sensitization in chronic headaches: a multi-method study. J Headache Pain. 2008;9(5):295-300. https://doi.org/10.1007/s10194-008-0061-7
  21. Campi LB, Jordani PC, Tenan HL, Camparis CM, Gonçalves DA. Painful temporomandibular disorders and central sensitization: implications for management-a pilot study. Int J Oral Maxillofac Surg. 2017;46(1):104-110. https://doi.org/10.1016/j.ijom.2016.07.005
  22. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, Giani C, Zbinden AM, Radanov BP. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain. 2001;17(4):306-315. https://doi.org/10.1097/00002508-200112000-00004
  23. Bevilaqua-Grossi D, Pegoretti KS, Goncalves MC, Speciali JG, Bordini CA, Bigal ME. Cervical mobility in women with migraine. Headache. 2009;49(5):726-731. https://doi.org/10.1111/j.1526-4610.2008.01233.x
  24. Fernandez-de-Las-Penas C, Cuadrado ML, Arendt-Nielsen L, Pareja JA. Side-to-side differences in pressure pain thresholds and pericranial muscle tenderness in strictly unilateral migraine. Eur J Neurol. 2008;15:162-168. https://doi.org/10.1111/j.1468-1331.2007.02020.x
  25. Shirokov VA, Potaturko AV. Efficacy and safety of meloxicam (Movalis) introduction in the trigger zone in lumbar sciatica syndrome. Effektivnaya Farmakoterapiya. Nevrologiya. 2017;5(38):56-60. (In Russ.)
  26. García Rodríguez LA, Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology. 2007;132(2):498-506. https://doi.org/10.1053/j.gastro.2006.12.007
  27. Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff V, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom M, Corrao G. Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ. 2016; 354:i4857. https://doi.org/10.1136/bmj.i4857
  28. McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):e1001098. https://doi.org/10.1371/journal.pmed.1001098
  29. Dreiser RL, Le Parc JM, Vélicitat P, Lleu PL. Oral meloxicam is effective in acute sciatica: two randomised, double-blind trials versus placebo or diclofenac. Inflamm Res. 2001;50(1):17-23. https://doi.org/10.1007/PL00022375
  30. Xu S, Rouzer CA, Marnett LJ. Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond. IUBMB Life. 2014;66(12):803-811. https://doi.org/10.1002/iub.1334
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.